Vito J. Palombella, Chief Scientific Officer at INFINITY PHARMACEUTICALS, INC. (INFI), sold 879 shares at $12.87 ($11K) on 2014-07-01, disclosed to the SEC on 2014-07-02.
Scheduled sale ($11k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| INFI | SELL | 2015-06-16 | $52K | — | Filing → |
| INFI | SELL | 2014-12-16 | $77K | — | Filing → |
| INFI | SELL | 2014-11-28 | $71K | — | Filing → |